Literature DB >> 28011269

Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits.

R Preston Mason1, Samuel C R Sherratt2.   

Abstract

Widely available fish oil dietary supplements (DS) may contain fats and oxidized lipids in addition to the beneficial omega-3 fatty acids (OM3FAs) for which they are purchased. Little is known about the potential biological effects of these oxidized lipids. The objective of this study was to assess the fatty acid content, oxidation products, and biological effects of leading fish oil DS available in the United States. Three top-selling fish oil DS in the US were included in this analysis. Fatty acid composition was measured using gas chromatography. Lipid oxidation (primary and secondary products) was measured by spectroscopy in both DS and a prescription OM3FA product. OM3FAs were also isolated and concentrated from DS and were tested for the ability to inhibit copper-induced oxidation of human small dense low-density lipoprotein particles (sdLDL) in vitro. Fish oil DS were found to contain more than 30 different fatty acids, including 10 to 14 different saturated species comprising up to 36% of the total fatty acid content. Levels of OM3FAs also varied widely among DS (33%-79%). Primary (peroxide), secondary (anisidine), and total oxidation products exceeded maximum levels established by international standards of quality in the DS but not the prescription OM3FA product. Oxidation of sdLDL was inhibited by >95% (P < 0.001) with non-oxidized forms of OM3FA but not with OM3FAs isolated from DS, which were a mixture of oxidized and non-oxidized OM3FAs. These data indicate that levels of saturated fat and oxidized OM3FAs found in common DS may interfere with their intended/potential biological benefits.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dietary supplements; Fish oils; Lipid oxidation; Omega-3 fatty acids

Mesh:

Substances:

Year:  2016        PMID: 28011269     DOI: 10.1016/j.bbrc.2016.12.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises - A Contemporary Review.

Authors:  Richard Kones; Scott Howell; Umme Rumana
Journal:  Med Princ Pract       Date:  2017-11-29       Impact factor: 1.927

Review 2.  Current regulatory guidelines and resources to support research of dietary supplements in the United States.

Authors:  Regan L Bailey
Journal:  Crit Rev Food Sci Nutr       Date:  2018-11-13       Impact factor: 11.176

Review 3.  Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.

Authors:  Renato Quispe; Abdulhamied Alfaddagh; Brigitte Kazzi; Fawzi Zghyer; Francoise A Marvel; Roger S Blumenthal; Garima Sharma; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

Review 4.  Cardio-Protective Properties and Health Benefits of Fish Lipid Bioactives; The Effects of Thermal Processing.

Authors:  Alexandros Tsoupras; Chloe Brummell; Ciara Kealy; Karolis Vitkaitis; Shane Redfern; Ioannis Zabetakis
Journal:  Mar Drugs       Date:  2022-03-02       Impact factor: 5.118

Review 5.  Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA).

Authors:  Eliot A Brinton; R Preston Mason
Journal:  Lipids Health Dis       Date:  2017-01-31       Impact factor: 3.876

6.  Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.

Authors:  Gerard Bannenberg; Harry B Rice
Journal:  Adv Ther       Date:  2020-07-09       Impact factor: 3.845

Review 7.  New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease.

Authors:  R Preston Mason
Journal:  Curr Atheroscler Rep       Date:  2019-01-12       Impact factor: 5.113

8.  Methodology for altering omega-3 EPA+DHA and omega-6 linoleic acid as controlled variables in a dietary trial.

Authors:  Beth A MacIntosh; Christopher E Ramsden; Gilson Honvoh; Keturah R Faurot; Olafur S Palsson; Angela D Johnston; Chanee Lynch; Paula Anderson; Daria Igudesman; Daisy Zamora; Mark Horowitz; Susan Gaylord; John D Mann
Journal:  Clin Nutr       Date:  2021-05-12       Impact factor: 7.643

9.  Omega-3 polyunsaturated fatty acids do not fluidify bilayers in the liquid-crystalline state.

Authors:  Augusta De Santis; Yaiza Varela; Jesús Sot; Gerardino D'Errico; Félix M Goñi; Alicia Alonso
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

10.  Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.

Authors:  R Preston Mason; Peter Libby; Deepak L Bhatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-26       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.